LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities &...

11
LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator

Transcript of LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities &...

Page 1: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCHSigne Denmark, SCTR Research Opportunities & Collaborations

Ryan Mulligan, SCTR Grants & Contracts Navigator

Page 2: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

LETTER OF INTENT (LOI) PURPOSE

• to ensure that, in the event that a Clinical Trial Agreement (CTA) is not executed, that:• MUSC research teams are compensated for the time and effort associated

with preparation and initial submission of IRB and other required regulatory and financial documents; 

• Institutional Review Board (IRB) review fees are paid for by the sponsor 

• to improve MUSC research team efficiency by enabling budget and CTA negotiations and regulatory submissions to occur in parallel.

Page 3: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

RESPONSIBILITIES

• General administration: MUSC Office of Research and Sponsored Programs

• Specific studies: MUSC Principal Investigator’s Department

• Feedback related to utilization: SCTR SUCCESS Center

Page 4: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

APPLICABLE GUIDELINES

• As with any agreement, ORSP will not sign a LOI until the ePDS is routed and approved by the Department.

• Any changes to LOI language must be reviewed and approved by ORSP.

Page 5: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

TIMING

• To expedite study start up, the ideal time to utilize the LOI is upon notification of site selection.

Page 6: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

PROCESS – PI’S DEPARTMENT

• Populating the Medical University of South Carolina (MUSC) Authorization for IRB Review Fee and Research Team Preparation of IRB Submission Documents Fee with:• Department, Division • Date, Funding Entity, Protocol Title, Protocol Number • Principal Investigator • Department/Division fees

• Any other changes to the LOI will require tracking and review by ORSP.

• The study team will submit the document in PDF form to the Funding Entity for signature.

Page 7: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

PROCESS – PI’S DEPARTMENT

• If the Funding Entity requests to make changes to the LOI:• Funding Entity will be required to track requested changes• Study team must route the ePDS so that ORSP can begin the LOI negotiations with the

Funding Entity

• Once the signed LOI document is returned to the MUSC study team:• PI signs• Study team submits to ORSP for full execution via ePDS

• The MUSC PI’s Department will be responsible for routing the ePDS associated with the LOI funds in order to trigger account set up.

• Once the research contract is fully executed, the PI’s Department will email their ORSP administrator the revised internal budget including the newly negotiated study budget (including the fees agreed to in the LOI).

Page 8: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

PROCESS – ORSP

• Reviewing and negotiating the potential track changes to the LOI document, if requested by the Funding Entity.

• Verifying that the tracked changes to the LOI are acceptable, accepting the changes and providing a PDF version of the document to the funding entity for signature.

• Providing institutional signature once the Funding Entity and PI signatures have been obtained and providing the fully signed version to the Funding Entity and study team.

Page 9: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

WHAT HAPPENS WHEN THE CTA IS EXECUTED?

• The LOI becomes null and void once a CTA is executed.

• The funds associated with the LOI should be included in the negotiated budget and the executed CTA.

Page 10: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

WHAT IF A CTA IS NEVER EXECUTED?

• If the study goes to the IRB, the research team must wait until the IRB fee is automatically charged and then the department may move the remaining funds (less F & A) to a general research account.

• If the IRB submission does not make it to the Board before the study is cancelled, then the department can move all of the funds (less F & A) to a general research account.

Page 11: LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

FEEDBACK ON LOI UTILIZATION

• Please contact the SCTR SUCCESS Center at [email protected] or 792-8300 with feedback related to utilization of the LOI.

Questions?